Affimer News and Research

RSS
Avacta to launch Affimer-based ELISA test for SARS-CoV-2 virus detection

Avacta to launch Affimer-based ELISA test for SARS-CoV-2 virus detection

Avacta enters into manufacturing agreement with Abingdon Health for rapid SARS-CoV-2 antigen test

Avacta enters into manufacturing agreement with Abingdon Health for rapid SARS-CoV-2 antigen test

Avacta expands multi-target collaboration with LG Chem Life Sciences

Avacta expands multi-target collaboration with LG Chem Life Sciences

Neil Bell appointed as Chief Development Officer of Avacta Life Sciences

Neil Bell appointed as Chief Development Officer of Avacta Life Sciences

Avacta appoints COVID-19 rapid antigen test manufacturing partner

Avacta appoints COVID-19 rapid antigen test manufacturing partner

Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy

Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy

Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test

Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test

Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test

Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test

Avacta and Integumen team up for detection of novel coronavirus in waste water

Avacta and Integumen team up for detection of novel coronavirus in waste water

Avacta provides update on COVID-19 rapid antigen test development partnership with Cytiva

Avacta provides update on COVID-19 rapid antigen test development partnership with Cytiva

Avacta provides update on Affimer therapy for COVID-19 infection

Avacta provides update on Affimer therapy for COVID-19 infection

Avacta provides update on COVID-19 antigen diagnostic test development with Adeptrix

Avacta provides update on COVID-19 antigen diagnostic test development with Adeptrix

Avacta and Medusa19 enter into a distribution agreement for COVID-19 antigen test

Avacta and Medusa19 enter into a distribution agreement for COVID-19 antigen test

Avacta's SARS-COV-2 neutralizing Affimer reagents show therapeutic potential for COVID-19

Avacta's SARS-COV-2 neutralizing Affimer reagents show therapeutic potential for COVID-19

Developing a COVID-19 antigen test

Developing a COVID-19 antigen test

Avacta Group plc forms COVID-19 antigen diagnostic collaboration with Adeptrix

Avacta Group plc forms COVID-19 antigen diagnostic collaboration with Adeptrix

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

Avacta partners with Cytiva to develop a rapid test for COVID-19

Avacta partners with Cytiva to develop a rapid test for COVID-19

Avacta demonstrates initial proof-of-concept for TMAC drug conjugates in pre-clinical study

Avacta demonstrates initial proof-of-concept for TMAC drug conjugates in pre-clinical study

Avacta and Daewoong Pharmaceutical announce joint venture to develop novel cell and gene therapies

Avacta and Daewoong Pharmaceutical announce joint venture to develop novel cell and gene therapies